Short and Long-term Outcomes Among High-Volume vs Low-Volume Esophagectomy Surgeons at a High-Volume Center.


Journal

Seminars in thoracic and cardiovascular surgery
ISSN: 1532-9488
Titre abrégé: Semin Thorac Cardiovasc Surg
Pays: United States
ID NLM: 8917640

Informations de publication

Date de publication:
2022
Historique:
received: 30 08 2021
accepted: 13 09 2021
pubmed: 25 9 2021
medline: 24 11 2022
entrez: 24 9 2021
Statut: ppublish

Résumé

To determine associations between surgeon volume and esophagectomy outcomes at a high-volume institution. All esophagectomies for esophageal cancer at our institution from August 2005 to August 2019 were reviewed. Cases were divided by surgeon into low, <7 cases/year, vs high volume, ≥7 cases/year, based on Leapfrog Group recommendations. Surgeons remained 'high-volume' after one year of ≥7 cases. Demographics, comorbidities, course of care, and long-term outcomes were compared. In total, 1029 cases were evaluated; 120 performed by low-volume surgeons vs 909 by high-volume surgeons. Never-smokers, atrial fibrillation, and clinical Stage IVa patients were associated with high-volume surgeons. Other demographics were similar. Low-volume surgeons did more open cases, 45.8% vs 14.5%, P < 0.01. Low-volume surgeons had more complications than high-volume surgeons (71.7% vs 57.6%, P < 0.01), specifically Grade II and III (59.2% vs 46.8%, P = 0.01, and 44.2% vs 27.0%, P <0.01). No differences were seen in anastomotic leak rate, 90-day mortality, recurrences, 5-year overall survival (46.7% low-volume vs 49.3% high-volume, P = 0.64), or 5-year disease-free survival (35.7% low-volume vs 42.2% high-volume, P = 0.27). In multivariable logistic regression for Grade III or higher complications, high-volume surgeons had an odds ratio of 0.56 (95% confidence interval 0.36-0.87) for complications. Our study found higher rates of open esophagectomies and complications in low-volume esophagectomy surgeons compared to high-volume surgeons at the same, high-volume institution. However, low-volume surgeons were not associated with worse survival outcomes compared to high-volume surgeons. Low-volume esophagectomy surgeons may benefit from mentoring and support to improve perioperative outcomes; these efforts are underway at our institution.

Identifiants

pubmed: 34560249
pii: S1043-0679(21)00422-6
doi: 10.1053/j.semtcvs.2021.09.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1340-1350

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Daniel Dolan (D)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts. Electronic address: daniel.dolan@icloud.com.

Abby White (A)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts.

Daniel N Lee (DN)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts.

Emanuele Mazzola (E)

Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

Emily Polhemus (E)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts.

Suden Kucukak (S)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts.

Jon O Wee (JO)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts.

Scott J Swanson (SJ)

Brigham and Women's Hospital, Division of Thoracic Surgery, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH